US2011301214A1PendingUtilityA1

Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol

47
Individually held — no corporate assignee on recordPriority: Feb 13, 2009Filed: Feb 12, 2010Published: Dec 8, 2011
Est. expiryFeb 13, 2029(~2.6 yrs left)· nominal 20-yr term from priority
Inventors:Daniel W. Gil
A61P 25/06A61P 29/00A61P 25/04A61P 23/00A61K 31/4174A61K 31/4164C07D 233/64
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein is a pharmaceutical composition comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol and methods of using the composition to treat chronic pain.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         2 . The pharmaceutical composition of  claim 1 , wherein the composition comprises a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         3 . The pharmaceutical composition of  claim 1 , wherein the composition comprises a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         4 . A method for the treatment of pain, the method comprising administering to a patient in need of such treatment a pharmaceutical composition comprising a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         5 . The method of  claim 4 , wherein the pain is chronic pain. 
     
     
         6 . The method of  claim 5 , wherein the chronic pain is neuropathic pain. 
     
     
         7 . The method of  claim 5 , wherein the chronic pain is associated with fibromyalgia. 
     
     
         8 . The method of  claim 5 , wherein the chronic pain is allodynia. 
     
     
         9 . The method of  claim 4 , wherein the pain is visceral pain. 
     
     
         10 . The method of  claim 4 , wherein administering the pharmaceutical composition does not sedate the patient. 
     
     
         11 . The method of  claim 4 , wherein the composition comprises a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         12 . The method of  claim 4 , wherein the composition comprises a compound represented by 
       
         
           
           
               
               
           
         
       
     
     
         13 . The method of  claim 9 , wherein visceral pain is pain associated with interstitial cystitis, urinary tract infections. 
     
     
         14 . The method of  claim 4 , wherein the pain is headache pain. 
     
     
         15 . The method of  claim 14 , wherein headache pain is migraine.

Join the waitlist — get patent alerts

Track US2011301214A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.